FdaApplication
ANDA 216809
Identifiers
- fda_app_no: ANDA216809
Properties
| Property | Value |
|---|---|
| applicant_name | GLAND PHARMA LTD |
| application_type | ANDA |
| approval_date | 2023-01-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KETAMINE HYDROCHLORIDE | KETAMINE HYDROCHLORIDE | EQ 50MG BASE/ML | INJECTABLE;INJECTION |
| KETAMINE HYDROCHLORIDE | KETAMINE HYDROCHLORIDE | EQ 100MG BASE/ML | INJECTABLE;INJECTION |
| KETAMINE HYDROCHLORIDE | KETAMINE HYDROCHLORIDE | EQ 10MG BASE/ML | INJECTABLE;INJECTION |
3 products